Back to Agenda
Session 7: Relative Efficacy versus Relative Effectiveness – the Future
Session Chair(s)
François Meyer, MD
Advisor to the President, International Affairs
French National Authority for Health (HAS), France
- Current challenges in the assessment of relative efficacy/effectiveness
- The need for comparative data
- Role of EUnetHTA moving forward
- Cooperation between EMA and EUnetHTA: current status and perspectives
Speaker(s)
Leeza Osipenko, PhD, MSc
Leeza Osipenko, PhD, MSc
National Institute for Health and Care Excellence (NICE), United Kingdom
Head of Scientific Advice
Kristin Svanqvist, MPharm
Kristin Svanqvist, MPharm
Amgen, Norway
Governmental Affairs Manager
Michael Berntgen, PhD
Michael Berntgen, PhD
European Medicines Agency, Netherlands
Head of Scientific Evidence Generation
Have an account?